Forte Biosciences GAAP EPS of -$0.96 beats by $0.04
Source: SeekingAlpha
2025-08-14 17:13:53 ET
More on Forte Biosciences
- Forte Biosciences stock falls after pricing capital raise of $75M via securities offering
- Seeking Alpha’s Quant Rating on Forte Biosciences
- Historical earnings data for Forte Biosciences
- Financial information for Forte Biosciences
Read the full article on Seeking Alpha
For further details see:
Forte Biosciences GAAP EPS of -$0.96 beats by $0.04
Forte Biosciences Inc.
NASDAQ: FBRX
FBRX Trading
-3.39% G/L:
$28.885 Last:
30,183 Volume:
$28.24 Open:
FBRX Latest News
March 04, 2026 04:01:00 pm
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
November 24, 2025 04:01:00 pm
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
November 14, 2025 09:00:00 am
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
FBRX Stock Data
$368,166,620
11,787,846
0.33%
18
N/A
Biotechnology & Life Sciences
Healthcare
US
Dallas
